pre-update Archives

Blog

A Bird’s Eye View on Rare Diseases: Key Drug Development Considerations for Thyroid Eye Disease

New therapeutics discovery and development for ocular diseases have been traditionally associated with a low…

Certara2021 年 12 月 15 日

Press Release

Certara 宣布推出 Pinnacle 21 Enterprise 软件

New metrics and analytics capabilities enable informed decision making for biopharmaceutical clients PRINCETON, N.J., Dec.…

Certara2021 年 12 月 13 日

Article

发现数据 — 需要新的架构来支持新模态

Certara2021 年 12 月 2 日

On-Demand Webinar

预测和驯化免疫原性：生物药物策略

Immunogenicity is the ability of a foreign substance, such as a drug or vaccine, to…

Certara2021 年 11 月 19 日

Article

Accelerating the establishment of precision medicine using PK-PD/TD modeling

Certara’s Japan team first met Dr. Kobuchi when he was studying Pharmacometrics at university for…

Certara2021 年 11 月 18 日

Article

Leveraging real-world data to meet payers’ needs

Certara2021 年 11 月 15 日

Article

Drug Discovery World：科学情报在药物发现中的价值

Certara2021 年 11 月 9 日

Conference

PHUSE EU Connect

Certara2021 年 11 月 9 日

Announcement

Certara Launches Fellowship Program in Africa for Applied Pharmacometrics Training

PRINCETON, N.J.— 2021 年 11 月 8 日 -- Certara, Inc, a global leader in biosimulation, today announced…

Certara2021 年 11 月 8 日

Blog

开发靶向共价抑制剂药物：3关键考虑因素

Traditional mechanisms of drug action rely on the reversible, noncovalent interaction of a ligand with…

Certara2021 年 11 月 5 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

pre-update

A Bird’s Eye View on Rare Diseases: Key Drug Development Considerations for Thyroid Eye Disease

Certara 宣布推出 Pinnacle 21 Enterprise 软件

发现数据 — 需要新的架构来支持新模态

预测和驯化免疫原性：生物药物策略

Accelerating the establishment of precision medicine using PK-PD/TD modeling

Leveraging real-world data to meet payers’ needs

Drug Discovery World：科学情报在药物发现中的价值

PHUSE EU Connect

Certara Launches Fellowship Program in Africa for Applied Pharmacometrics Training

开发靶向共价抑制剂药物：3关键考虑因素

订阅时事通讯

快捷链接

解决方案

联系我们